^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    activated CIK and bispecific antibody

    i
    Associations
    News

    Trials

    Company:
    Benhealth Biopharma
    Drug class:
    CD3 agonist, MUC1 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer (BK2016.01) (NCT03146637)
    Phase 2
    Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
    Recruiting
    Last update posted :
    02/01/2021
    Initiation :
    05/01/2017
    Primary completion :
    01/27/2021
    Completion :
    01/28/2021
    GPC3
    |
    activated CIK and bispecific antibody • activated CIK-anti-CD3/MUC1/CEA/EpCAM/GPC3 antibody